Topic Hub
24 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 24 of 24 clinical reviews.
A physician-reviewed guide to using suvorexant (Belsomra) after bariatric surgery, covering pharmacokinetics, dosing adjustments, drug interactions, and safety data relevant to the post-bariatric patient.
Read clinical reviewDoes suvorexant (Belsomra) affect appetite and food cravings? A physician-reviewed deep dive into the orexin system, clinical trial data, weight signals, and what patients should monitor.
Read clinical reviewA clinician-level review of suvorexant (Belsomra) and its effects on bone mineral density, fracture risk, and fall mechanics, with primary-literature citations throughout.
Read clinical reviewA clinician-level review of the suvorexant (Belsomra) cancer risk signal, covering FDA pharmacovigilance data, preclinical findings, clinical trial safety databases, and current prescribing guidance.
Read clinical reviewA physician-reviewed deep dive into suvorexant (Belsomra) and its long-term cardiovascular effects, covering blood pressure, heart rate, arrhythmia risk, and comparative safety data from primary literature.
Read clinical reviewA physician-reviewed deep dive into how suvorexant (Belsomra) affects memory, next-day alertness, and long-term cognition, with primary-literature citations and practical dosing guidance.
Read clinical reviewA physician-reviewed comparison of compounded suvorexant vs brand-name Belsomra, covering pharmacology, FDA approval status, bioequivalence data, dosing, cost, and when each option is appropriate.
Read clinical reviewA GRADE-level analysis of suvorexant (Belsomra) clinical trials, sleep-outcome effect sizes, adverse-event data, and prescribing guidance for clinicians and informed patients.
Read clinical reviewA clinician-reviewed deep-dive into reported hair loss and skin changes with suvorexant (Belsomra), covering mechanism, incidence data, differential diagnosis, and management steps.
Read clinical reviewA clinician-level review of suvorexant (Belsomra) and liver function: metabolism pathways, hepatic impairment dosing, ALT/AST findings from key trials, and what monitoring is actually warranted.
Read clinical reviewA clinician-level review of how suvorexant (Belsomra) affects mood, anxiety, depression, and psychiatric safety, covering key trials, FDA labeling, and practical prescribing guidance.
Read clinical reviewA clinician-level review of how suvorexant (Belsomra) affects metabolism, thermogenesis, and energy expenditure, with primary-literature citations and dosing context.
Read clinical reviewA physician-reviewed deep dive into suvorexant (Belsomra) microdosing protocols, covering FDA-approved dose ranges, off-label low-dose use, pharmacokinetics, safety data from Herring et al. And SUNRISE trials, and clinical decision guidance.
Read clinical reviewA clinician-level review of suvorexant (Belsomra) and muscle preservation: pharmacology, fall and atonia risk, practical dose strategies, and how orexin antagonism compares to sedative-hypnotics for sarcopenia-vulnerable patients.
Read clinical reviewWhy suvorexant (Belsomra) stops working, and exactly what clinicians can do about it. MD/PharmD-level plateau troubleshooting with primary-literature citations.
Read clinical reviewComplete clinical guide to the suvorexant (Belsomra) pre-surgery hold window: recommended discontinuation timing, pharmacokinetic rationale, anesthetic interactions, and perioperative management protocols.
Read clinical reviewDoes stopping suvorexant (Belsomra) cause rebound insomnia or withdrawal? A physician-reviewed deep dive into the clinical trial data, discontinuation protocols, and what to expect.
Read clinical reviewA clinician-grade review of suvorexant (Belsomra) and kidney safety: pharmacokinetics, renal dosing, clinical trial data, and how it compares to Z-drugs and benzodiazepines in patients with CKD.
Read clinical reviewLearn when and how to safely restart Belsomra (suvorexant) after acute illness, with dosing guidance, drug interaction review, and primary-literature citations reviewed by HealthRX physicians.
Read clinical reviewHow seasonal changes in light exposure, sleep architecture, circadian rhythm, and comorbid mood disorders affect Belsomra (suvorexant) dosing, efficacy, and safety. Physician-reviewed, primary-literature-backed guidance.
Read clinical reviewA physician-reviewed deep dive into suvorexant (Belsomra) and sexual function. Covers trial data, proposed mechanisms, dose considerations, and clinical guidance for patients and prescribers.
Read clinical reviewA clinician-level review of how suvorexant (Belsomra) changes sleep architecture, including REM, NREM, slow-wave sleep, and wake time, based on polysomnography data from Phase 3 trials.
Read clinical reviewPhysician-reviewed guide to using suvorexant (Belsomra) for travel and timezone-shift insomnia. Covers dosing schedules, jet lag protocols, shift-work strategies, drug interactions, and safety data from primary clinical trials.
Read clinical reviewA physician-reviewed, week-by-week guide to what happens during your first month on Belsomra (suvorexant), covering onset, side effects, dose titration, and what the clinical evidence actually shows.
Read clinical review